Does ursolic acid build muscle or improve metabolic health?

Ursolic acid acts through several distinct biological pathways, which makes it a compound with broad but interrelated effects.

Muscle Preservation via IGF-1 and Akt

One of the most studied effects of ursolic acid involves the IGF-1/PI3K/Akt signaling pathway — a key regulator of muscle protein synthesis and maintenance. In a landmark study, ursolic acid was shown to increase skeletal muscle mass in mice, with downstream effects including upregulation of genes that promote glucose uptake in muscle cells (hexokinase-II) and recruitment of blood vessels to muscle tissue¹. The compound also reduced diet-induced obesity, improved glucose tolerance, and decreased fatty liver disease in the same animal model.

The proposed mechanism is that ursolic acid mimics some of the anabolic signaling triggered by exercise — activating Akt and mTOR, pathways that tell muscle cells to grow and resist breakdown. A secondary pathway involves irisin, an exercise-induced hormone that crosses into muscle and promotes growth³. In an 8-week resistance training study in men, the group receiving ursolic acid showed significantly higher serum irisin levels and greater gains in grip strength compared to the training-only group³.

Anti-Inflammatory Action via NF-κB, AP-1, and NF-AT

Chronic inflammation is a driver of muscle atrophy, metabolic disease, and many age-related conditions. Ursolic acid has been shown to suppress three key inflammatory transcription factors — NF-κB, AP-1, and NF-AT — which control the expression of pro-inflammatory cytokines like TNF-α, IL-1β, IL-6, and IL-17². This was demonstrated in human T cells, B cells, and macrophages treated with various inflammatory stimulants. Ursolic acid also inhibits the enzymes cyclooxygenase-2 (COX-2) and lipoxygenase (LOX), which are the same targets as NSAIDs like ibuprofen⁴.

This multi-pathway approach to inflammation suppression is notable: instead of blocking one molecule, ursolic acid works upstream at the signaling level.

Food Sources

Ursolic acid is found naturally in:

• Apple peel — the skin contains 50–70 mg per 100g of peel; peeling removes most of it
• Rosemary — one of the richest herb sources; dried rosemary contains significant amounts
• Basil, oregano, thyme — meaningful concentrations in dried forms
• Cranberries and blueberries — moderate concentrations
• Prunes, peppermint, lemon verbena — additional dietary sources

Eating apple peel and cooking regularly with rosemary provides ongoing low-dose exposure. Whether this food-level exposure produces the health effects seen in studies using concentrated doses is not established.

Supplementation

Supplement doses in human studies have ranged from 150–450 mg/day. Bioavailability is a real concern — ursolic acid is poorly water-soluble, and standard powder formulations may absorb inconsistently. Some formulations use phytosome complexes (bound to phosphatidylcholine) to improve absorption, similar to approaches used for curcumin and quercetin.

Human evidence to date is mixed: some trials show increases in irisin and modest strength benefits with resistance training; others using 400 mg/day in men on high-protein diets found no significant effect on muscle mass or cardiometabolic markers compared to placebo⁵. The gap between animal models and human outcomes likely reflects differences in dose, bioavailability, and baseline conditions.

See our quercetin page for another plant flavonoid with overlapping anti-inflammatory mechanisms. For related muscle-support compounds, see creatine and magnesium.

Foundational Animal Study: Kunkel et al. (2012)

The most cited study on ursolic acid and muscle came from researchers at the University of Iowa, published in PLoS ONE (PMID 22745735). The team screened gene expression signatures of human skeletal muscle atrophy and identified ursolic acid as a natural compound that could reverse atrophy-associated gene patterns. In mouse models, ursolic acid supplementation increased skeletal muscle mass by approximately 15% and brown fat mass, while simultaneously reducing diet-induced obesity, glucose intolerance, and fatty liver disease.

The mechanistic finding was that ursolic acid increased skeletal muscle IGF-1 and insulin signaling, activating the Akt/mTOR pathway — the canonical anabolic cascade responsible for muscle protein synthesis. The compound also upregulated hexokinase-II (glucose metabolism in muscle) and VEGF-a (blood vessel recruitment to muscle). This study is foundational but limited to animal models; the translation to human physiology requires caution.

Anti-Inflammatory Mechanisms: Checker et al. (2012)

Checker et al. (PMID 22363615) investigated ursolic acid's anti-inflammatory effects in human immune cells — T cells, B cells, and macrophages. The study demonstrated dose-dependent suppression of NF-κB, AP-1, and NF-AT activation across multiple inflammatory stimulants including lipopolysaccharide, PMA, and concanavalin A. Downstream, ursolic acid reduced production of TNF-α, IL-6, IL-17, and MCP-1. It also inhibited T cell proliferation and reduced the generation of reactive oxygen species in activated immune cells.

Importantly, the authors showed inhibition at concentrations likely achievable with supplementation. The simultaneous suppression of NF-κB (the master inflammatory switch), AP-1 (a cytokine transcription factor), and NF-AT (critical for T cell activation) distinguishes ursolic acid from more targeted anti-inflammatory compounds.

Human Resistance Training Study: Bang et al. (2014)

Bang et al. (PMID 25352765), published in the Korean Journal of Physiology and Pharmacology, enrolled 16 healthy men who performed 8 weeks of supervised resistance training (6 sessions/week, 5 sets of 26 exercises at 60–80% of 1-rep maximum). Nine participants also took ursolic acid supplementation; 7 trained without it.

The ursolic acid group showed significantly higher serum irisin levels (p<0.05), with corresponding increases in grip strength compared to the training-only group. IGF-1 was also elevated. Irisin, a myokine released during exercise, is associated with muscle hypertrophy, fat browning, and bone metabolism — making its increase biologically plausible as a mechanism for ursolic acid's muscle effects. This study was small and unblinded, limiting the strength of conclusions, but it represents one of the few positive human signals in this area.

Comprehensive Review: Luan et al. (2022)

Luan et al. (PMID 34517797), in Mini Reviews in Medicinal Chemistry, synthesized the mechanistic literature on ursolic acid's anti-inflammatory activity. The review confirms that the primary pathways include: inhibition of histamine release from mast cells, suppression of COX and LOX enzyme activity, reduction of nitric oxide and reactive oxygen species production, blockade of NF-κB signaling cascades, downregulation of inflammatory cytokine expression, and inhibition of elastase and complement activation.

The authors also reviewed therapeutic applications in animal models including arthritis, colitis, neuroinflammation, and metabolic syndrome, all with positive preclinical outcomes. The gap between these results and human clinical data is a recurring theme.

Human Meta-Analysis: Rafiee et al. (2024)

The most rigorous assessment of ursolic acid's effects in humans comes from a 2024 systematic review and meta-analysis published in Future Cardiology (PMID 38923885). Six articles, found by searching up to February 2023, were included, with ursolic acid doses ranging from about 51 to 450 mg/day. The pooled analysis found no statistically significant changes in body weight, BMI, waist circumference, body fat percentage, lean body mass, blood pressure, fasting glucose, insulin, or triglycerides compared with control groups, and the authors concluded that ursolic acid supplementation had no significant effect on cardiometabolic risk factors in adults.

This is a humbling finding relative to the animal literature. The meta-analysis does not preclude benefit — it reflects the current state of the human evidence, which remains insufficient to confirm the metabolic effects seen in preclinical models.

Overall Evidence Assessment

Ursolic acid has robust mechanistic plausibility: it acts on well-validated inflammatory and anabolic pathways, at concentrations potentially achievable with supplementation. The animal literature is consistent and compelling. Human evidence is in early stages and currently mixed — one small resistance training study shows positive effects on irisin and strength, while a 2024 meta-analysis of six studies found no significant metabolic effects. The likely limiting factors are bioavailability of standard formulations and insufficient study durations and sample sizes.

Ursolic acid is present in everyday foods — particularly apple peel and rosemary — at low but consistent doses. Supplementation remains investigational from a human evidence standpoint. Its safety profile appears good based on available data; the compound has no established toxicity at the doses used in human trials.